Lag3 and PD-1 pathways regulate NFAT-dependent TCR signalling programmes during early CD4 + T cell activation
Preprint
Abstract
Summary: Lag3 and PD-1 are immune checkpoints that regulate T cell responses and are current immunotherapy targets. Yet how they function to control early CD4 + T cell activation remains unclear. Here, we show that the PD-1 and Lag3 pathways exhibit layered control of the early CD4 + T cell activation process, with the effects of Lag3 more pronounced in the presence of PD-1 pathway co-blockade (CB). RNA-sequencing revealed that CB drove an early NFAT-dependent transcriptional profile, including promotion of ICOS hi T follicular helper (Tfh) cell differentiation. NFAT pathway inhibition abolished CB-induced upregulation of NFAT-dependent co-receptors ICOS and OX40, whilst unaffecting the NFAT-independent gene Nr4a1 . Mechanistically, Lag3 and PD-1 pathways functioned additively to regulate the duration of T cell receptor (TCR) signals during CD4 + T cell re-activation. Our data therefore reveal that PD-1 and Lag3 pathways converge to additively regulate TCR signal duration and NFAT-dependent transcriptional activity during early CD4 + T cell re-activation. Highlights: PD-1 and Lag3 pathways exhibit layered control of early CD4 + T cell activation Their co-blockade enhances NFAT-dependent TCR transcriptional programmes Inhibition of NFAT signalling reverses the functional effects of PD-1 and Lag3 co-blockade Mechanistically, PD-1 and Lag3 function to additively regulate TCR signal duration during re-activation of CD4 + T cellsKeywords
This publication has 66 references indexed in Scilit:
- Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunityImmunity, 2022
- Locked and loaded: strong TCR signaling primes anti-PD-1 therapyTrends in Immunology, 2021
- Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responsesCell, 2021
- Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strengthImmunity, 2021
- Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and DurationCell Reports, 2020
- Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionCancer Immunology, Immunotherapy, 2019
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3Cell, 2019
- Confusing signals: Recent progress in CTLA-4 biologyTrends in Immunology, 2015
- Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responsesEuropean Journal of Immunology, 2003
- The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cellsEuropean Journal of Immunology, 2003